Company Search:
Advanced Search
Sponsored Links
Opiant Pharmaceuticals Inc Company Snapshot
Opiant Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Opiant Pharmaceuticals Inc with three other miscellaneous service companies in North America: Microbix Biosystems Inc (2016 sales of 9.52 million Canadian Dollars [US$7.26 million] ), Pharmaxis Ltd of the United States ($13.50 million of which 80% was Bronchitol and Aridol), and Clinuvel Pharmaceuticals Limited which is also based in the United States ($5.11 million of which 100% was Biotechnology).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Opiant Pharmaceuticals Inc
  Stock Performance Chart for Opiant Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 9.14
(Figures in Canadian Dollars)
1 Week 17.0%   13 Weeks 4.4%  
4 Weeks -13.2%   52 Weeks -26.9%  
Opiant Pharmaceuticals Inc Key Data:
  Ticker: OPNT Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 13,092,044
(Year Ending Jan 2017).
Employees: 3
  Currency: Canadian Dollars Market Cap: 18,209,841
  Fiscal Yr Ends: July Shares Outstanding: 1,992,433
  Share Type: Common Closely Held Shares: 218,170
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.